MA
EDIT icon

MCF Advisors’s Editas Medicine EDIT Stock Holding History

MCF Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175 Hold
54
– – ﹤0.01% 1379
2026
Q1 		$134 Buy
54
+53
+5,300% +$112 ﹤0.01% 1318
2025
Q4 		$3 Hold
1
– – ﹤0.01% 1130
2025
Q3 		$4 Hold
1
– – ﹤0.01% 963
2025
Q2 		$3 Hold
1
– – ﹤0.01% 896
2025
Q1 		$2 Hold
1
– – ﹤0.01% 907
2024
Q4 		$2 Hold
1
– – ﹤0.01% 990
2024
Q3 		$4 Hold
1
– – ﹤0.01% 1001
2024
Q2 		$5 Sell
1
-10
-91% -$56 ﹤0.01% 1021
2024
Q1 		$82 Buy
+11
New +$91 ﹤0.01% 974

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MCF Advisors's EDIT Position: Q2 2026 in Review

MCF Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 54 shares worth $175. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

MCF Advisors first reported a position in EDIT in Q1 2024 and has held it in 10 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • MCF Advisors held 54 shares of Editas Medicine worth $175 as of Q2 2026.
  • MCF Advisors left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1379 holding.
  • MCF Advisors first reported a position in Editas Medicine in Q1 2024 and has held it in 10 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.